A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease

Late-onset Alzheimer's disease is a prevalent age-related polygenic disease that accounts for 50-70% of dementia cases. This study highlights microglia, immune cells and protein catabolism as relevant to late-onset Alzheimer's disease, while identifying and prioritizing previously unidentified genes of potential interest.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 Currently, only a fraction of the genetic variants underlying Alzheimer's disease have been identified.
• 2 Here we show that increased sample sizes allowed identification of seven previously unidentified genetic loci contributing to Alzheimer's disease.
• 3 This study highlights microglia, immune cells and protein catabolism as relevant to late-onset Alzheimer's disease, while identifying and prioritizing previously unidentified genes of potential interest.

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: